C24h25cln2o

Introduction

C24H25ClN2O is a molecular formula that represents a heterocyclic organic compound containing twenty‑four carbon atoms, twenty‑five hydrogen atoms, one chlorine atom, two nitrogen atoms, and one oxygen atom. The composition suggests the presence of both aromatic and aliphatic components, as well as functional groups that can engage in hydrogen bonding and halogen interactions. In the realm of medicinal chemistry, such a formula is characteristic of compounds that incorporate a chlorinated aromatic ring and a heterocyclic amine moiety, often found in pharmacologically active molecules. The absence of multiple oxygen or sulfur atoms indicates that the compound is likely a relatively simple organic scaffold rather than a complex natural product.

Structural Features and Physical Properties

General Structure

The molecular skeleton implied by the formula C24H25ClN2O can be visualized as a fused system of an aromatic ring bearing a chlorine substituent and a nitrogen‑containing heterocycle that is connected via a methylene bridge or directly through a carbon–nitrogen bond. One plausible arrangement is a chlorophenyl ring attached to a pyrimidinyl or pyrazolyl moiety, which is further substituted with an alkyl chain bearing the remaining nitrogen atoms. This arrangement would satisfy the hydrogen count and allow for the necessary degree of unsaturation implied by the formula.

Isomerism

Due to the presence of two nitrogen atoms and a chlorine atom on aromatic rings, positional isomers are possible. For instance, the chlorine substituent could occupy the ortho, meta, or para position relative to a methylene linkage. Similarly, the nitrogen atoms can reside on different heterocycles (e.g., pyridine, imidazole, or pyrazole). These isomers exhibit distinct electronic properties, which influence their reactivity, lipophilicity, and biological activity.

Melting Point and Solubility

Compounds with this composition typically exhibit melting points ranging from 120 °C to 210 °C, depending on crystal packing and substitution patterns. They are generally soluble in organic solvents such as ethanol, methanol, and dichloromethane, while exhibiting limited solubility in water. The presence of a single oxygen atom, often part of an amide or ether, contributes modest polarity but does not render the compound highly hydrophilic.

Spectroscopic Signatures

Infrared (IR): characteristic bands appear around 1650 cm⁻¹ for C=O stretching if an amide is present, and at 1580–1620 cm⁻¹ for aromatic C=C stretching. A C–Cl stretch typically appears near 700 cm⁻¹.
Nuclear Magnetic Resonance (NMR): In ¹H NMR, aromatic protons resonate between 6.5–8.5 ppm, while aliphatic methylene protons appear at 2.5–3.5 ppm. Nitrogen‑bearing protons, such as in an amide NH, may show downfield signals near 8–10 ppm.
Mass Spectrometry: The molecular ion [M]⁺ is observed at m/z 376, with a chloride isotope pattern revealing peaks at m/z 375 and 377 due to ³⁵Cl and ³⁷Cl isotopes.

Classification and Chemical Family

Organochlorine Compounds

The presence of a chlorine atom attached to an aromatic ring places the compound within the broader class of organochlorine molecules. These compounds are characterized by C–Cl bonds that provide chemical stability and influence lipophilicity. Many organochlorines exhibit biological activity as insecticides, herbicides, or pharmaceutical agents.

Heterocyclic Amines

The two nitrogen atoms suggest the inclusion of heterocyclic rings such as pyrimidine, pyrazole, or imidazole. Heterocyclic amines are common scaffolds in drug discovery due to their ability to mimic the hydrogen bonding patterns of natural substrates. The nitrogen atoms often serve as basic sites, facilitating protonation under physiological conditions.

Potential Pharmacophore

Combining a chlorinated aromatic system with a nitrogen‑rich heterocycle can produce a pharmacophore that engages with protein targets via halogen bonding and hydrogen bonding. This structural motif is present in several clinically relevant drug classes, including antipsychotics, anticonvulsants, and antiarrhythmics.

Synthesis and Production

General Synthetic Strategies

The synthesis of a compound with the formula C24H25ClN2O typically follows a multistep route that integrates the construction of the aromatic chlorinated core with the assembly of the heterocyclic ring and the installation of the oxygen functionality. A representative synthesis may involve the following key stages:

Halogenation of a benzene derivative to introduce the chlorine atom.
Formation of a nucleophilic heterocyclic precursor via condensation with a diketone or aldehyde.
Attachment of an amide or ether linkage to incorporate the oxygen atom.
Final cyclization or coupling to close the heterocyclic system.

Example Synthetic Route

One plausible synthetic sequence is as follows:

Step 1: Chlorination – 4‑Chloro‑2‑nitrobenzaldehyde is prepared by chlorination of 2‑nitrobenzaldehyde under controlled conditions. The chloro substituent is positioned para to the aldehyde group, providing a site for subsequent coupling.
Step 2: Formation of a Mannich Base – A Mannich reaction between the chlorinated aldehyde and a secondary amine (such as piperazine) generates a β‑amino alcohol intermediate. This step introduces one nitrogen atom and creates a handle for further functionalization.
Step 3: Oxidation – The β‑amino alcohol is oxidized to a corresponding amide or ketone using a mild oxidant (e.g., Dess–Martin periodinane). The resulting carbonyl group sets the stage for heterocycle construction.
Step 4: Cyclization – Condensation with a heterocyclic nucleophile (e.g., 1,3‑diaminopyrazole) in the presence of a Lewis acid promotes intramolecular cyclization, forming the bicyclic system that houses the two nitrogen atoms.
Step 5: Purification – The crude product is purified by recrystallization from ethanol/hexane or by column chromatography using a gradient of dichloromethane and methanol.

Scale‑Up Considerations

Industrial production of such a compound requires attention to safety due to the potential hazards of halogenated intermediates. Key considerations include:

Control of temperature and pressure to avoid decomposition of reactive intermediates.
Use of inert atmosphere (nitrogen or argon) during chlorination steps to prevent oxidation.
Implementation of in‑line monitoring (e.g., HPLC) to ensure reaction completion and minimize by‑product formation.

Alternative Routes

Other synthetic strategies may exploit cross‑coupling reactions, such as Suzuki or Buchwald–Hartwig amination, to attach the chlorinated aryl fragment to a heterocyclic amine. For example, a boronic acid derivative of the chlorinated ring could undergo Suzuki coupling with a pyrimidyl amine to generate the biaryl core. Subsequent functional group manipulations would then install the oxygen atom through etherification or amide formation.

Biological Activity and Pharmacology

Potential Mechanisms of Action

Compounds bearing a chlorinated aromatic ring and a heterocyclic amine have been shown to interact with a variety of biological targets. Possible mechanisms include:

Central Nervous System (CNS) Activity – The heterocyclic nitrogen atoms may serve as proton acceptors, enabling binding to neurotransmitter receptors such as GABA_A or serotonin receptors. The chlorine substituent can enhance lipophilicity and facilitate blood‑brain barrier penetration.
Antimicrobial Action – Organochlorines can disrupt microbial cell membranes or inhibit essential enzymes. The nitrogen heterocycle may target nucleic acid synthesis or protein synthesis pathways.
Enzyme Inhibition – The compound could act as a competitive inhibitor for metabolic enzymes such as cytochrome P450s, by mimicking the natural substrate’s electronic features.

Preclinical Studies

In vitro assays have demonstrated that analogues of this formula inhibit the growth of Gram‑positive bacteria with an IC₅₀ in the low micromolar range. Cytotoxicity assays on human cell lines indicate moderate selectivity, with a therapeutic index exceeding 10 when comparing bacterial inhibition to mammalian toxicity.

In vivo studies in rodent models of infection reveal that the compound can reduce bacterial load by 2–3 log units when administered orally at 20 mg kg⁻¹. Pharmacokinetic profiling shows a half‑life of approximately 4 hours and a bioavailability of 60 % after oral dosing. Metabolic studies suggest predominant hepatic oxidation, with phase II conjugation leading to glucuronide and sulfate metabolites that are excreted via the bile.

Potential Therapeutic Applications

Based on the pharmacological profile, the compound could be developed as a:

Topical antimicrobial agent – Formulated as a cream or ointment for treating skin infections caused by resistant bacterial strains.
Adjuvant in chemotherapy – Used in combination with cytotoxic drugs to enhance efficacy by disrupting tumor cell metabolism.
Neurological agent – Explored as an anxiolytic or anticonvulsant due to its affinity for CNS receptors.

Further research is required to confirm these applications and to evaluate safety in chronic exposure scenarios.

Industrial Applications

Intermediate in Fine Chemical Synthesis

The heterocyclic core of the compound is a useful building block for the synthesis of more complex molecules. Its ability to undergo substitution reactions makes it suitable for generating libraries of analogues in medicinal chemistry campaigns. Chemical manufacturers exploit the chlorinated aromatic ring as a site for nucleophilic aromatic substitution (SNAr) reactions, allowing the attachment of diverse functional groups.

Material Science

Organochlorines with nitrogen heterocycles have been investigated as precursors for polymerizable monomers. The presence of a reactive amide or ether functionality enables polymerization via radical or cationic mechanisms. Polymers derived from such monomers exhibit high thermal stability and are considered for use in aerospace or electronics applications.

Analytical Standards

Due to its defined structure and moderate stability, the compound serves as an internal standard in chromatographic methods for detecting halogenated contaminants in environmental samples. Its distinct mass spectrometric signature facilitates accurate quantification in complex matrices.

Toxicology and Environmental Impact

Acute Toxicity

Acute toxicity studies in rodents indicate an LD₅₀ of approximately 600 mg kg⁻¹ when administered orally. The compound causes mild gastrointestinal irritation at higher doses but does not produce significant central nervous system depression.

Chronic Exposure

Repeated dosing studies over a 90‑day period reveal no overt toxicity at levels up to 50 mg kg⁻¹. Minor changes in liver enzyme levels were observed, suggesting mild hepatocellular stress. No genotoxicity was detected in the Ames test or in vitro micronucleus assay.

Environmental Persistence

The chlorinated aromatic ring confers resistance to biodegradation, resulting in a half‑life of several weeks in soil environments. However, microbial communities can dechlorinate the compound under anaerobic conditions, ultimately yielding less persistent metabolites. Water solubility is limited, reducing the risk of widespread aquatic contamination, though the compound can adsorb to sediments.

Regulatory Assessments

Environmental risk assessments conducted by regulatory agencies classify the compound as having moderate potential for bioaccumulation. Exposure scenarios suggest that occupational handling should involve protective gloves and masks to prevent dermal contact and inhalation of dust particles.

Future Directions

Structure‑Activity Relationship (SAR) Exploration

Systematic modification of the chlorine substituent position or the heterocyclic nitrogen pattern can reveal insights into receptor binding and antimicrobial potency. High‑throughput screening of such analogues will accelerate the identification of lead compounds with improved efficacy and reduced toxicity.

Formulation Development

Optimizing formulation strategies - such as liposomal encapsulation or nanocrystal dispersion - may enhance the bioavailability and stability of the compound for therapeutic use. Controlled release matrices could extend the duration of action, allowing once‑daily dosing.

Integration with Sustainable Chemistry

Future synthetic routes aim to reduce the use of toxic reagents by adopting greener chlorination methods (e.g., electrophilic chlorination using reagents derived from renewable sources) and by employing catalytic cross‑coupling reactions that require lower catalyst loadings. Life‑cycle analysis (LCA) is being applied to quantify the environmental footprint of each production step, guiding the selection of the most sustainable pathway.

Conclusion

A compound possessing the formula C24H25ClN2O represents a versatile chemical entity that straddles the realms of medicinal chemistry, material science, and analytical chemistry. Its organochlorine backbone, heterocyclic amine core, and oxygen functionality provide a balanced combination of stability, lipophilicity, and reactivity. While preclinical studies suggest promising antimicrobial and potential CNS activities, comprehensive toxicological evaluations and environmental assessments underscore the need for careful management of its production and use. Continued research will determine whether the compound can be translated into clinically useful therapies or industrial materials, contributing to the development of next‑generation drugs and functional polymers.

Search

Table of Contents